Bruker Corporation (BRKR) to Post Q3 2018 Earnings of $0.33 Per Share, Jefferies Group Forecasts

Bruker Corporation (NASDAQ:BRKR) – Jefferies Group increased their Q3 2018 earnings per share estimates for Bruker Corporation in a research note issued to investors on Thursday. Jefferies Group analyst B. Couillard now anticipates that the medical research company will post earnings per share of $0.33 for the quarter, up from their prior forecast of $0.32. Jefferies Group also issued estimates for Bruker Corporation’s Q4 2018 earnings at $0.40 EPS, FY2018 earnings at $1.35 EPS and FY2019 earnings at $1.52 EPS.

BRKR has been the topic of a number of other reports. J P Morgan Chase & Co raised Bruker Corporation from an “underweight” rating to a “neutral” rating and set a $28.00 price target on the stock in a research note on Friday, November 3rd. Citigroup Inc. lifted their price target on Bruker Corporation from $29.00 to $34.00 and gave the stock a “neutral” rating in a research note on Friday, November 3rd. Goldman Sachs Group, Inc. (The) reaffirmed a “sell” rating and issued a $24.00 price target on shares of Bruker Corporation in a research note on Tuesday, September 26th. Bank of America Corporation raised Bruker Corporation from an “underperform” rating to a “neutral” rating and set a $34.00 price target on the stock in a research note on Friday, November 3rd. Finally, BidaskClub raised Bruker Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, August 16th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $29.64.

COPYRIGHT VIOLATION WARNING: “Bruker Corporation (BRKR) to Post Q3 2018 Earnings of $0.33 Per Share, Jefferies Group Forecasts” was first posted by Markets Daily and is the property of of Markets Daily. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.themarketsdaily.com/2017/11/14/bruker-corporation-brkr-to-post-q3-2018-earnings-of-0-33-per-share-jefferies-group-forecasts.html.

Shares of Bruker Corporation (NASDAQ:BRKR) traded up $0.56 during trading hours on Monday, hitting $32.39. The stock had a trading volume of 657,700 shares, compared to its average volume of 632,791. The company has a debt-to-equity ratio of 0.65, a current ratio of 2.60 and a quick ratio of 1.60. The firm has a market capitalization of $5,130.00, a price-to-earnings ratio of 27.20, a PEG ratio of 2.69 and a beta of 1.05. Bruker Corporation has a 12-month low of $21.03 and a 12-month high of $35.16.

Bruker Corporation (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, November 2nd. The medical research company reported $0.29 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.27 by $0.02. The firm had revenue of $435.60 million for the quarter, compared to analyst estimates of $415.45 million. Bruker Corporation had a return on equity of 25.83% and a net margin of 8.85%. The business’s revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 earnings per share.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 22nd. Shareholders of record on Monday, December 4th will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 0.49%. Bruker Corporation’s dividend payout ratio is currently 17.02%.

In other Bruker Corporation news, VP Mark Munch sold 21,061 shares of Bruker Corporation stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $29.97, for a total value of $631,198.17. Following the sale, the vice president now owns 60,524 shares in the company, valued at $1,813,904.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 35.20% of the stock is owned by insiders.

Large investors have recently bought and sold shares of the business. Acrospire Investment Management LLC raised its position in Bruker Corporation by 496.1% in the second quarter. Acrospire Investment Management LLC now owns 3,827 shares of the medical research company’s stock valued at $110,000 after purchasing an additional 3,185 shares during the period. SG Americas Securities LLC purchased a new stake in Bruker Corporation in the second quarter valued at $111,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of Bruker Corporation by 11.3% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,599 shares of the medical research company’s stock valued at $133,000 after buying an additional 467 shares during the period. Smithfield Trust Co. purchased a new stake in shares of Bruker Corporation in the 2nd quarter valued at $138,000. Finally, The Manufacturers Life Insurance Company raised its holdings in shares of Bruker Corporation by 7.1% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 5,003 shares of the medical research company’s stock valued at $144,000 after buying an additional 331 shares during the period. Institutional investors own 65.47% of the company’s stock.

About Bruker Corporation

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.

Earnings History and Estimates for Bruker Corporation (NASDAQ:BRKR)

Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply